PubHive Integrates with Microsoft Azure Active Directory

PubHive customers can now enable users to automatically sign-on to the PubHive Navigator cloud software platform using secure single sign-on technology powered by Microsoft Azure Active Directory

Creative Enzymes Releases Restriction Enzymes for Molecular Biology Research

Alfa Chemistry to Present at the Upcoming ACS Spring 2023 Conference

Alfa Chemistry, a chemical company focused on supplying high-quality chemicals and materials for both academia and the industry, today announced that members of its Senior Management Team are scheduled to participate in the upcoming ACS Spring 2023 Conference in March at Indiana Convention Center, located in 100 S Capitol Ave, Indianapolis, IN 46225.

Alfa Chemistry Announces to Participate in the Upcoming Pittcon Conference & Exposition 2023

The New York-based chemical vendor Alfa Chemistry recently announced its attendance at the upcoming Pittcon Conference & Exposition 2023. This five-day event will take place at Pennsylvania Convention Center from 18th – 22nd March 2023.

Creative Proteomics Enhances Your Project with Cell Surface Proteomics Service

Creative Proteomics Cytokine Boosts Cancer Research with Cancer Cytokines Assay

Pronalyse Announces the Launch of Epitope Mapping Service Utilizing HDX-MS Technology

Cancer Support Community and Equiva Health partner to create new industry standard for digital cancer support

Equiva Health recently announced a partnership with the Cancer Support Community—the largest professionally led non-profit cancer support network—to launch a pilot program in Minnesota to bring a new, digital model of cancer care to communities that lack access. CSC will use Equiva’s health relationship management platform to bring CSC’s services and resources to patients via broadband-enabled tablets. Those who qualify will also be able to apply for the FCC’s Affordable Connectivity Program via Equiva and ISP provider Infiniti Mobile, providing low to no-cost broadband connection to support access to CSC's resources Overall this partnership is an effort to bring digital cancer care and telemedicine services to underserved communities to improve health equity among these populations.

Form Bio Names Linda Murray as Chief Financial Officer

Form Bio, the breakthrough computational life sciences platform, today announced the appointment of Linda Murray as Chief Financial Officer.

Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain

Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain

BRIM Biotechnology announces first patient enrollment in pivotal Phase 3 clinical trial of BRM421 for Dry Eye Disease

BRIM Biotechnology Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that the first patient has been enrolled in its Phase 3 clinical trial of BRM421 for the treatment of Dry Eye Disease (DED).

CD Formulation Upgrades Its Database of Pharmaceutical Excipients, Cosmetic Ingredients, and Food Ingredients

Common Food Additives: Preservatives, Thickeners, and Sweeteners

Fascinating Coordination Complexes and Their Applications

Coordination chemistry investigates the characteristics of coordination compounds formed by the interaction between metal atoms or ions and inorganic, organic ions or molecules, as well as their bonding, structure, reaction, classification, and preparation.

Jumo Health Launches Suite of Services to Drive Health Equity in Clinical Trials

Expanded offerings will increase Black representation in clinical trials, ensuring that new medicines are safe and effective for people of color.

CD Biosciences Provides Peptidomimetic Development Services to FacilitateTherapeutic Development

CD Biosciences Supplies Services for Single-cell Transcriptome Sequencing and Analysis for TME Research

CD Biosciences Launches C. elegans Lysis Kit for Genotyping to Apply in Genetic and Developmental Studies

CD Biosciences Releases Drosophila CRISPR/Cas9 Genome Editing to Study Gene Function and Drug Screening

Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease

Cardio Diagnostics Holdings Inc, an artificial intelligence-powered precision cardiovascular medicine company, announced the launch of PrecisionCHD™, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.